Sciwind Biosciences

Sciwind Biosciences

China - Hangzhou
Biotechnology
WebsiteLinkedIn

Focus: Oral peptide delivery

Sciwind Biosciences is a life sciences company focused on Oral peptide delivery.

Metabolic DiseasesInfectious DiseasesRespiratory
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

XW003 injection
Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT06335134A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Phase 1
Phase 1
Clinical Trials (1)
NCT05642403A Study of XW001 in Healthy Adult Subjects
Phase 1
XW003 injection
Obese Adolescents
Phase 1
Clinical Trials (1)
NCT07143227A Study of XW003 Injection in Chinese Adolescents With Obesity
Phase 1
T2026
Obesity
Phase 1
Clinical Trials (1)
NCT05184322XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
Phase 1
Phase 1
Clinical Trials (1)
NCT05579314XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
Phase 1
Phase 1
Clinical Trials (1)
NCT04389775To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants
Phase 1
Phase 1/2
Clinical Trials (1)
NCT05779995A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV
Phase 1/2
ecnoglutide tablets
Overweight and/or Obesity
Phase 1/2
Clinical Trials (1)
NCT07243171A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Phase 1/2
XW003 injection
Obesity
Phase 2
Clinical Trials (1)
NCT07073417A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Phase 2
XW003
Obesity
Phase 2
Clinical Trials (1)
NCT05111912Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Phase 2
Phase 2
Clinical Trials (1)
NCT05083117Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
Phase 2
Phase 3
Clinical Trials (1)
NCT07434050A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Phase 3
Phase 3
Clinical Trials (1)
NCT07387094A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Phase 3
Ecnoglutide high dosage
T2DM
Phase 3
Clinical Trials (1)
NCT05680129A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Phase 3
Ecnoglutide Low Dosage
Weight Management
Phase 3
Clinical Trials (1)
NCT05813795A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Phase 3
Ecnoglutide
T2DM
Phase 3
Clinical Trials (1)
NCT05680155A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Phase 3

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
Portfolio: 16 clinical trials